DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Gabelli & Co. Downgrades Tetraphase Pharmaceutical to Sell

Gabelli & Co. analyst Kevin Kedra downgrades Tetraphase Pharmaceutical (NASDAQ:TTPH) from Hold to Sell.

Benzinga · 03/17/2020 10:46

Gabelli & Co. analyst Kevin Kedra downgrades Tetraphase Pharmaceutical (NASDAQ:TTPH) from Hold to Sell.